Q&A library
Long-tail life sciences insurance questions, answered in depth.
Detailed answers to the specific questions life-sciences operators ask before signing a sponsor MSA, registering as a 503B, joining a GPO, or onboarding a new sponsor relationship. Each entry is a full-page treatment of one question.
Question
Does a 503B outsourcing facility need dedicated product recall coverage?
Why FDA-recall extensions on standard products liability policies are typically insufficient for 503B outsourcing facilities, and what dedicated recall coverage looks like.
Read the full answer →
Question
Which MSA clauses require additional insured status for products and completed operations?
How sponsor MSAs require additional insured for products and completed operations, why blanket AI endorsements often exclude it, and what ISO CG 20 37 looks like in practice.
Read the full answer →
Question
Does clinical trial liability insurance cover investigator-sponsors and clinical sites?
How clinical trial liability policies handle investigator-sponsor coverage, what sponsor IND-holder responsibilities look like for insurance, and where CROs sit in the structure.
Read the full answer →
Question
How does USP 797 / 800 compliance compare to FDA cGMP for insurance underwriting?
USP 797 and USP 800 vs FDA cGMP - which standard applies to which compounder, how insurance carriers underwrite each, and what compliance documentation matters at renewal.
Read the full answer →
Question
What insurance options do GLP-1 compounding pharmacies have right now?
The GLP-1 compounding insurance landscape - carrier exclusions, products liability availability, druggist PL options, and how 503A and 503B compounders are navigating the firestorm.
Read the full answer →
Question
What insurance coverage does a medical device manufacturer need to supply a GPO?
Group purchasing organization (GPO) supplier insurance requirements for medical device manufacturers - products liability limits, additional insured, hospital purchase contract pass-through, and credentialing platform enforcement.
Read the full answer →
Question
What insurance does PBM credentialing require for a pharmacy?
Pharmacy benefit manager (PBM) credentialing insurance requirements - druggist professional liability, products, cyber, HIPAA, and carrier rating. Why credentialing failure locks the pharmacy out of reimbursement.
Read the full answer →
Question
Does a 503A compounding pharmacy actually need products liability insurance?
When 503A compounding pharmacies need products liability coverage, why druggist professional liability alone is insufficient at scale, and how PBM credentialing and accreditation interact with products coverage.
Read the full answer →
Question
How much cyber liability does a CRO handling PHI typically carry?
Cyber liability sizing for CROs handling protected health information - limits by subject count, PHI sensitivity, and sponsor-required minimums. HIPAA breach response, regulatory defense, and ransomware coverage.
Read the full answer →
Question
How do I evaluate the insurance section of a sponsor MSA before signing?
A practical walkthrough for life-sciences operators reviewing the insurance schedule of a sponsor master services agreement - what to look for, what to push back on, and how to identify hidden compliance traps.
Read the full answer →
Question
Does a pre-revenue clinical-stage biotech need D&O insurance?
Why pre-revenue clinical-stage biotechs typically need D&O coverage despite having no commercial product - investor disputes, regulatory investigations, employment claims, and Side A protection.
Read the full answer →
Question
Where do CDMOs and CROs have leverage to negotiate sponsor MSA insurance terms?
A practical map of which sponsor MSA insurance terms are negotiable versus universally enforced - limits, AI wording, indemnity, survival, and form requirements.
Read the full answer →
Question
How does CDMO claims history affect insurance renewal pricing?
How insurance carriers underwrite CDMO renewals based on prior claims experience, what counts as a "clean" history, and how operators can mitigate the impact of prior claims at renewal.
Read the full answer →
Question
How much does life sciences insurance cost by company revenue?
Typical Texas life-sciences insurance premium ranges by company revenue band and sub-vertical - CDMO, CRO, medical device, biotech, compounding pharmacy, 503B outsourcing.
Read the full answer →
Question
What insurance does a clinical lab need for laboratory-developed tests (LDTs)?
Insurance for clinical and diagnostic labs running laboratory-developed tests (LDTs) - products liability with LDT extensions, professional liability for diagnostic accuracy, cyber/HIPAA, and the regulatory landscape after the FDA LDT rule vacatur.
Read the full answer →
Question
What insurance does a biotech spinout from an academic institution need?
Insurance considerations for biotech spinouts from academic medical centers and universities - IP/license-back implications, IIS coverage, D&O sized to early-stage governance, shared facilities, and the typical Series A program shape.
Read the full answer →
Question
What cyber insurance do biotechs need for IPO readiness?
How clinical-stage biotechs approaching IPO should size cyber and information-security insurance - disclosure obligations, SEC cyber rules, EDGAR cyber incident reporting, and the interaction with D&O securities exposure.
Read the full answer →
Question
How do you structure insurance for a multi-site CDMO acquisition?
Insurance considerations for CDMO M&A - representations and warranties insurance, tail coverage on target programs, integration of new facilities into existing property and products policies, and the timeline from LOI through close.
Read the full answer →
Question
How much does a sponsor MSA insurance review cost?
Typical cost ranges for sponsor MSA insurance reviews by life-sciences brokers and specialty counsel - what the review covers, when to engage outside review, and the cost vs benefit calculation.
Read the full answer →
Question
How does workers compensation work for biotech research staff?
Workers compensation considerations for biotech and pharma research operations - class codes for laboratory and clinical staff, BSL-2/3/4 lab environment effects, and how biotech-specific exposures (chemical, biological, radiation) factor into WC underwriting.
Read the full answer →
Question
How does workers compensation work for CRO and clinical research staff?
Workers compensation for contract research organizations - class codes for clinical monitors, CRAs, central lab and bioanalytical staff, the travel exposure that defines CRO WC, foreign voluntary WC for ex-US trials, and sponsor MSA statutory requirements.
Read the full answer →
Question
How does workers compensation work for compounding pharmacy staff?
Workers compensation for 503A and 503B compounding pharmacies - pharmacy class codes, USP 800 hazardous drug exposure, sterile compounding injury risk, how 503B operators classify closer to drug manufacturing, and Texas non-subscriber issues.
Read the full answer →
Question
How does workers compensation work for medical device manufacturers?
Workers compensation for medical device manufacturers - how class codes follow the actual production process (cleanroom assembly, machining, sterilization), ethylene oxide and chemical exposure, GPO and hospital supplier statutory WC requirements, and premium drivers.
Read the full answer →
Question
What workers compensation class codes apply to life sciences and laboratory staff?
Workers compensation class codes for life sciences and laboratory staff - analytical and chemical laboratory codes, drug research classifications, clerical and outside codes, how NCCI states differ from California (WCIRB) and other independent states, and misclassification audit risk.
Read the full answer →
Question
What does USP 800 require for compounding pharmacies, and how does it affect insurance?
USP General Chapter 800 requirements for hazardous drug handling at compounding pharmacies - containment engineering controls, PPE, environmental monitoring, medical surveillance - and how USP 800 compliance affects workers compensation, products liability, druggist professional liability, and carrier appetite.
Read the full answer →
Question
Does a 503B outsourcing facility need Joint Commission certification?
Whether a 503B outsourcing facility needs Joint Commission Medication Compounding Certification (MCC) - legal requirement versus hospital-purchaser expectation, the insurance underwriting credit it provides, how it relates to FDA cGMP, and when it is worth pursuing.
Read the full answer →
Question
How do USP 797 inspection findings affect compounding pharmacy insurance?
How state board and USP 797 inspection observations affect compounding pharmacy insurance - why inspection history drives underwriting, the impact of the 2023 USP 797 revision, what carriers request at renewal, the cost of material findings, and how to build a favorable profile.
Read the full answer →
Question
How much umbrella (excess) liability does a life sciences company need?
How to size umbrella and excess liability for life sciences operators - CDMOs, CROs, biotech, medical device, 503B - against sponsor MSA, GPO, and hospital purchase contract total-limit requirements, what the umbrella does and does not cover, and typical limit bands.
Read the full answer →
Question
What is the difference between umbrella and excess liability for life sciences operators?
Umbrella vs excess liability for life sciences operators - how umbrella can drop down to fill gaps while follow-form excess only adds limits over a scheduled underlying policy, and why the distinction matters most for the products and completed operations tower.
Read the full answer →
Question
What umbrella or excess limits do sponsor MSAs and hospital contracts require?
What total liability limits pharmaceutical sponsor MSAs, GPO supplier agreements, and hospital purchase contracts require from life sciences operators - typical bands by segment, how the umbrella must extend additional insured up the tower, and how it shows on the certificate of insurance.
Read the full answer →
Question
Does property insurance cover validation losses at cGMP facilities?
How property insurance covers cGMP facility losses including batch and validation losses - drug-manufacturer property forms, cleanroom contamination, HVAC and environmental excursions, and the gap left by generic commercial property policies.
Read the full answer →
Question
Do pharmaceutical and biotech operators need environmental impairment liability insurance?
When pharma manufacturers, biotech operators, 503B outsourcing facilities, and contract testing labs need standalone environmental impairment liability (EIL) coverage - pollution exposures, solvent and API handling, radiopharmaceutical and biohazard scenarios.
Read the full answer →
Question
Can a CDMO share insurance with its sponsor under the MSA?
Whether CDMOs and pharma sponsors can share insurance programs under a master services agreement - the legal and practical limits, OCIP/CCIP structures, and why standalone CDMO programs remain standard.
Read the full answer →
Question
What insurance does a biotech IPO actually require?
The four insurance programs a clinical-stage biotech needs in place before an IPO or SPAC merger - transactional D&O, run-off D&O for the pre-IPO entity, EPLI sized to the new headcount profile, cyber for the new disclosure obligations - and the timing.
Read the full answer →
Question
How much does products liability insurance cost for a CDMO with $20M revenue?
Typical products liability premium ranges for a Texas pharma CDMO at $20M revenue - by product class, sponsor mix, and tower structure. What drives the spread, the gap between admitted and surplus-lines pricing, and where the unexpected costs live.
Read the full answer →
Question
What's the difference between products liability and product recall coverage?
Products liability covers third-party bodily injury and property damage from a defective product. Product recall coverage covers first-party costs of executing a recall (notification, retrieval, replacement, destruction). The two coverages respond to different parts of the same recall event.
Read the full answer →
Question
What insurance does a digital health / AI healthtech startup need before fundraising?
Digital health and AI healthtech startups face a different insurance profile than biotech or medical device - Tech E&O sized to enterprise SaaS terms, cyber sized to PHI/PHR volume, D&O at term sheet, and possibly clinical decision support liability depending on FDA classification.
Read the full answer →
Question
Can a 503A compounding pharmacy operate without products liability insurance?
A 503A pharmacy can technically operate without products liability since state law and PBM contracts typically require only druggist professional liability - but it is structurally exposed to patient injury claims that PL does not cover. The risk math rarely favors going without.
Read the full answer →
Question
What insurance does a medical device company need around 510(k) clearance?
Insurance program structure for medical device companies going through 510(k) clearance - products liability sizing at clearance vs at commercial launch, clinical trial liability for premarket studies, recall coverage architecture, D&O for VC-backed device startups.
Read the full answer →
Question
What insurance does a Software as a Medical Device (SaMD) company need?
SaMD companies face a double-coverage requirement - Tech E&O for the software dimension and products liability for the FDA-regulated medical device dimension. Coverage overlap, gap zones, and how AI-driven SaMD changes the underwriting question.
Read the full answer →
Question
What insurance does a CLIA-certified clinical laboratory need?
CLIA-certified clinical and molecular laboratories need professional liability for testing accuracy claims, cyber sized to PHI volume, products liability for any laboratory-developed tests (LDTs), and property programs that cover specialized instruments - plus E&O for any clinical advisory or interpretation services.
Read the full answer →
Question
What is the cheapest insurance program a pre-seed biotech startup needs to operate legally?
Minimum viable insurance for a pre-seed biotech startup - what you legally and contractually need versus what you can defer until Series A.
Read the full answer →
Question
Does the Texas LLC structure matter for life sciences insurance underwriting?
How Texas LLC, series LLC, and multi-entity structures affect life sciences insurance program design - named-insured wording, additional-insured passthroughs, and per-entity vs blanket policies.
Read the full answer →
Question
What is the difference between fiduciary liability and D&O insurance for a biotech with employee benefit plans?
Fiduciary liability covers ERISA breach-of-fiduciary-duty claims arising from employee benefit plan administration; D&O covers management decisions. The two coverages do not overlap and biotechs need both once they sponsor a 401(k) or similar plan.
Read the full answer →
Question
What insurance does an AI drug discovery startup need?
AI drug discovery startups operate at the intersection of biotech, SaaS, and AI/ML risk - the program combines tech E&O, cyber, D&O, IP infringement, and where the platform produces clinical decision support, SaMD-classification considerations.
Read the full answer →
Question
When does a biotech consider a captive insurance company versus a group captive?
Captive insurance companies become economically rational for biotechs at meaningful self-insurance retention size - typically $5M+ annual premium across the program. Group captives lower the threshold by aggregating multiple insureds.
Read the full answer →
Question
When does a life sciences company need foreign voluntary workers compensation coverage?
Foreign voluntary workers compensation covers US employees traveling internationally for business - clinical trial monitoring, CRO oversight, manufacturing audits. Standard US workers comp policies do not respond to injuries occurring outside the United States.
Read the full answer →
Question
Does biotech insurance cover patent infringement claims?
Standard biotech insurance policies do not cover patent infringement claims as a default; explicit IP infringement coverage is purchased as a sub-limit on E&O, as part of tech E&O, or as a standalone IP defense policy.
Read the full answer →
Question
What is the insurance difference between a 503B outsourcing facility compounding GLP-1 and a 503A pharmacy compounding GLP-1?
A 503B outsourcing facility compounding GLP-1 faces FDA-registered manufacturer products liability underwriting and hospital purchase contract insurance schedules; a 503A pharmacy compounding GLP-1 faces druggist professional liability and pharmacy-scale products liability with the same GLP-1 carrier-exclusion crisis affecting both.
Read the full answer →
Question
Does biotech D&O coverage need to change for a bridge financing or convertible note round?
Bridge financings and convertible note rounds typically do not require D&O policy changes, but a few specific structural elements (most-favored-nation provisions, lead-investor board observer rights, pay-to-play features) can trigger D&O renewal questions and limit changes.
Read the full answer →
Question
Which sponsor MSA insurance requirements are typically negotiable versus immovable?
Sponsor MSA insurance requirements vary widely in negotiability - limits are typically immovable for major pharma sponsors, additional-insured wording often allows alternative endorsements, notice-of-cancellation language is sometimes negotiable to standard ISO wording, and aggregate-per-project endorsements are typically achievable.
Read the full answer →
Question
Can pharmaceutical companies be held liable for their products?
Yes - pharmaceutical companies face strict liability, negligence, failure-to-warn, and design-defect claims for drug and device products. What that means for insurance program structure.
Read the full answer →
Question
What does pharmaceutical products liability insurance not cover?
The most common exclusions on pharma and medical device products liability policies: known defects, withdrawn products, recall first-party costs, off-label, contractual liability assumed without endorsement, and more.
Read the full answer →
Question
Who needs pharmaceutical products liability insurance?
Every operator in the pharmaceutical supply chain that touches a drug or device - CDMOs, biotech, 503B outsourcing, compounding pharmacies, medical device manufacturers, CROs - needs products liability coverage scaled to contract demands.
Read the full answer →
Question
What is clinical trial liability insurance?
Clinical trial liability insurance covers bodily injury and death claims from human study subjects participating in pharmaceutical, biotech, and medical device trials. What it covers, who needs it, and typical limits.
Read the full answer →
Question
What is 503B compounding insurance?
503B compounding insurance is the specialized program required for FDA-registered outsourcing facilities - products liability, recall, druggist professional, hospital additional insured, and cGMP-specific endorsements.
Read the full answer →
Question
Is a 503B compounding pharmacy FDA-approved?
503B outsourcing facilities are FDA-registered and FDA-inspected but their compounded products are not individually FDA-approved. The distinction matters for insurance and contract obligations.
Read the full answer →
Question
What is safer, 503A or 503B?
503B facilities operate under cGMP and ongoing FDA inspection; 503A pharmacies operate under state board oversight and USP compounding standards. Each is safe for its intended use case. The insurance question turns on contractual demands, not relative safety.
Read the full answer →
Question
Why are compounding pharmacies being shut down - and what insurance covers it?
FDA enforcement, state pharmacy board action, and carrier exclusions are closing compounding pharmacies in 2025-2026. What's actually driving closures and what insurance can and cannot do.
Read the full answer →
Question
What are the risks of CDMO operation that drive insurance requirements?
CDMO insurance is shaped by five recurring operator-side risks: sponsor MSA scope creep, products liability tower adequacy, recall execution capability, validation/cGMP downtime, and IP/trade secret leakage.
Read the full answer →
Question
How does a CDMO ensure regulatory compliance under sponsor MSA insurance demands?
Sponsor MSA insurance demands and FDA cGMP compliance are different problems - insurance evidences compliance but does not cause it. The operator-side discipline that satisfies both.
Read the full answer →
Question
How much is small business insurance for life sciences?
Annual insurance premium ranges for small life sciences businesses ($1M-$10M revenue) by sub-vertical - CDMO, CRO, biotech, compounding pharmacy, 503B, medical device, diagnostic lab. The cost drivers that move premium materially.
Read the full answer →
Question
How much does clinical trial liability insurance cost?
Clinical trial liability insurance typically costs $15K-$50K per study for Phase 1, $50K-$150K for Phase 2/3 multi-site, and $200K+ for global Phase 3 with EU sites and cell/gene therapy indications.
Read the full answer →
Question
What is druggist professional liability?
Druggist professional liability is dedicated coverage for service-side errors in dispensing, compounding, mislabeling, or BUD miscalculation - the pharmacy-specific equivalent of professional liability for service errors.
Read the full answer →
Question
What insurance does a digital health startup need?
Digital health startups need technology E&O sized to platform scope, cyber for PHI handling under HIPAA, products liability if FDA-cleared as SaMD, D&O if VC/PE backed, and clinical trial liability if conducting prospective studies.
Read the full answer →
Question
Do compounding pharmacies need recall insurance?
503A traditional compounders rarely need dedicated recall coverage; 503B outsourcing facilities typically need it as a hospital purchase contract condition at $3M-$10M first-party limits.
Read the full answer →
Question
How does Symplr / Reptrax credentialing work for medical device suppliers?
Symplr (now Vendormate) and Reptrax are hospital-side credentialing platforms enforcing GPO supplier insurance schedules. Suppliers upload COIs and endorsements; missing or non-compliant coverage suspends purchasing.
Read the full answer →
Question
Are labs covered by insurance? (Lab insurance and laboratory coverage explained)
Yes - diagnostic, clinical, pathology, molecular, and bioanalytical labs are covered by specialty lab insurance built around cyber, professional liability for diagnostic accuracy, and hospital reference-lab service-agreement compliance. Not the same as generic small-business insurance.
Read the full answer →
Question
What is the average cost of a pharmaceutical product recall?
Average pharmaceutical product recall cost runs $10M-$30M for an FDA Class II event at a mid-market manufacturer. Class I recalls escalate to $50M-$600M+ given litigation. Notification, retrieval, replacement, destruction, lost profit, and downstream litigation all stack.
Read the full answer →
Question
How to get insurance to cover GLP-1 compounding (after the FDA enforcement wave)?
After the March 2026 FDA enforcement wave ended the GLP-1 shortage list, most generalist carriers added GLP-1 exclusions. Coverage is still available through specialty markets that require dose protocols, prescriber credentialing documentation, and adverse-event workflows in place.
Read the full answer →
Question
Do startup biotechs need products liability insurance?
No - pre-commercial startup biotechs do not need products liability until commercialization approaches. Pre-revenue clinical-stage biotechs need D&O, clinical trial liability, cyber, EPLI, and IP/E&O instead.
Read the full answer →
Question
What insurance does a SaMD (software-as-a-medical-device) operator need?
SaMD operators need cyber as the primary product-liability vehicle ($10M-$50M sized to patient impact), algorithm liability for AI/ML errors, HIPAA Business Associate scope, Tech E&O for non-product services, and SOC 2 Type II documentation.
Read the full answer →
Question
What is the insurance difference between FDA Class II and Class III medical devices?
FDA Class II (510(k)) devices need $5M-$15M products tower with MDR liability extension. Class III (PMA) implantables need $25M-$100M+ tower on occurrence form non-negotiable, with long-tail considerations driven by 10-20+ year claim windows on implants.
Read the full answer →
Question
Does the sponsor or the CRO pay for clinical trial insurance?
The sponsor pays for clinical trial liability (CTL) - the sponsor holds the IND, sets the protocol, and bears the regulatory subject-protection obligation. The CRO pays for professional liability and E&O sized to monitoring scope.
Read the full answer →
Question
What insurance does a biotech need before Series A?
Before Series A: D&O ($1M-$5M, mandatory at term sheet), basic CGL, workers comp, cyber for IND data and drug master file ($1M-$3M), employment practices once headcount exceeds 10. Add clinical trial liability when first-in-human dosing approaches.
Read the full answer →
Question
How does a typical sponsor MSA insurance schedule read?
A typical pharmaceutical sponsor MSA insurance schedule requires: occurrence-form CGL ($1M/$2M), products liability ($5M-$10M), professional liability/E&O, workers comp, cyber, additional insured (CG 20 10 + CG 20 37), primary and non-contributory, waiver of subrogation, 30-day notice of cancellation. Survival 7+ years post-termination.
Read the full answer →
Question
What cyber insurance does a clinical laboratory need?
Clinical labs need cyber sized to annual specimen volume and PHI sensitivity - NOT headcount or revenue. $5M-$25M typical for mid-size labs; high-volume hospital reference labs scale to $50M+. HIPAA breach response, ransomware operational interruption BI, state genetic privacy regulatory defense, and contingent LIS/middleware vendor coverage.
Read the full answer →
Question
Do compounding pharmacies need products liability insurance?
503A compounding pharmacies typically need $1M/$2M products liability as a secondary line beneath druggist professional liability. 503B outsourcing facilities operate as drug manufacturers and need $5M-$10M products as the primary line.
Read the full answer →
Question
What types of insurance does a small life sciences company need?
The core insurance lines a small biotech, CRO, CDMO, medical device, or compounding company needs: general liability, products/professional liability, D&O, clinical trial, property, workers comp, cyber, and umbrella - and how to sequence them by stage.
Read the full answer →
Question
How do you choose an insurance broker for a life sciences company?
What to look for in a life sciences insurance broker: specialty carrier access, MSA and contract-review capability, claims advocacy, program architecture across stages, and the questions that separate a specialist from a generalist.
Read the full answer →
Question
What products liability insurance do medical device manufacturers need?
How medical device manufacturers size products liability insurance by device class (FDA Class I/II/III), what GPO and hospital purchase contracts require, and why the products/completed-operations endorsement is the load-bearing piece.
Read the full answer →